Cell Sorting Market Size, Share, and Industry Analysis By Offering (Products and Services), By Technology (Fluorescence-activated cell sorting (FACS), Magnetic-Activated Cell Sorting (MACS), Buoyancy-Activated Cell Sorting, and Others (Microbubbles, Flow Cytometry)), By Application (Drug Discovery & Development, Immunophenotyping, Sequencing, and Others (Medical Research, Biotechnology Research)), By End User (Pharma & Biotech Companies and Research and Academic Institutes), and Regional Forecast, 2026-2034

The global cell sorting market size was valued at USD 289.56 billion in 2025. The market is projected to grow from USD 316.51 billion in 2026 to USD 644.96 billion by 2034, exhibiting a CAGR of 9.31% during the forecast period.

The global cell sorting market grows rapidly because new instruments and research products help users sort cells faster with greater accuracy and analyse diverse biological properties. Cell sorting helps professionals separate unique cell groups from mixed samples by their physical traits and biological characteristics using flow cytometry equipment.

The rise of personalised medicine and cell-based therapy developments enhance the need for GMP-compliant and high-throughput cell sorting systems.

Cell Sorting Market Driver

Progress in Technology to Expand the Market

Continuous progress in technology powers the development of the cell sorting market. New spectroscopy technologies boost cell analysis by adding many measurement points quickly for a better look at cell characteristics.

Growth of Chronic Diseases to Advance the Market

The cell sorting industry grows quickly because chronic diseases grow in number, especially cardiovascular diseases, cancer, and autoimmune disorders. These diseases need us to study their effects on single-cell populations because their immune reactions and cell control problems are difficult to understand.

Cell Sorting Market Restraint

High-Priced Sorters to Pose Potential Impediments on this Market

High-priced sorters constrain market growth because these products are costly to purchase and maintain. Using state-of-the-art cell sorting systems that work with spectral flow cytometry or microfluidics requires a significant financial commitment. Advanced cell sorters need trained personnel to run and maintain them, which raises total costs.

Cell Sorting Market Opportunity

Merging of Automation and AI Technology to Create Opportunity in this Market

The cell sorting market benefits greatly from the merging of automation and artificial intelligence technology. Automation optimises sorting operations by simplifying tasks and lowering mistakes while making products move faster through this process. By evaluating modern cell sorter data output, AI systems find hidden relationships that stay unnoticed when manual operators process the data.

Segmentation

Key Insights

The report covers the following key insights:

• Market drivers, restraints and opportunities
• Influence of key industrial players and key developments
• Technological expenditure
• Research and development

Analysis by Offering

By offering, the cell sorting market is divided into products and services.

The market for cell sorting experiences high growth due to its essential products, which include instruments, reagents, and consumables. Modern instrument development, such as spectral flow cytometry and microfluidic sorters, boosts sorting efficiency while adding more tests and better focus to many practical applications.

Contract research organisations and core facilities that offer cell sorting services as well as equipment access drive market development.

Analysis by Technology

Based on Technology, the market is divided into Fluorescence-activated cell sorting (FACS), Magnetic-Activated Cell Sorting (MACS), Buoyancy-Activated Cell Sorting & Others (Microbubbles, Flow cytometry).

FACS technology produces most of the market growth because it offers precision and adaptable cell separation methods. FACS can separate cells based on their size and physical characteristics plus how strong they glow under fluorescence using fast-flow systems and special stains.

The cell sorting market continues to expand due to MACS, which uses magnetically labelled cells and separation techniques, especially in situations where pure viable cells are needed. MACS technology serves as an economical and straightforward method that matches FACS functions better than other applications, enabling clinical work.

Analysis by Application

Based on Application, the market is divided into Drug Discovery & Development, Immunophenotyping, Sequencing & Others (Medical Research, Biotechnology Research).

Cell sorting helps grow the pharmaceutical research businesses across the market. Researchers determine suitable drug targets and test compounds using cell sorting while measuring drug safety and safety profiles of different cell types.

The cell sorting market increases rapidly for both profit and knowledge due to its use in immunophenotyping tests. Cell sorting gives us a clear way to find out and measure distinct immune cell types through their marker and activity characteristics.

Analysis by End User

Based on End User, the market is divided into Pharma & Biotech Companies & Research and Academic Institutes.

Companies from the pharmaceutical and biotechnology sector drive the increase in cell sorting market opportunities. Drug development organisations use cell sorting instruments during every step of their drug research programs.

Basic research development at research facilities helps expand the cell sorting business thanks to their important role. Scientific centres use cell sorting tools to research basic existence facts and disease workings while creating new medical tests and health methods.

Regional Analysis

Based on region, the Cell Sorting market has been studied across North America, Europe, Asia Pacific, Latin America, and the Middle East & Africa.

North America, especially the U.S., owns most of the market share in cell sorting because of heavy investments in research and strong healthcare infrastructure alongside many essential business players. Government grants from the NIH and private funding enable North America to develop better cell sorting tools and create new uses for these technologies. The United States medical field leads because its pharmaceutical and biotechnology leaders use complex cell sorting procedures to create cell treatments and personalise medical care.

• According to NIH, North America has 250+ number of cell sorting labs.
• According to FDA, the percentage of biotech firms using cell sorting in North America is 68%.

The European market for cell sorting technologies expands steadily because it features extensive research activities combined with experienced personnel and advanced medical facilities. European countries, especially Germany, the U.K., and France, support cell biology research through leading medical institutions and pharma companies. Horizon Europe helps European scientists’ team up while EU funds support life sciences innovation through research projects.

The Asia Pacific cell sorting market expands quickly because healthcare sectors invest more funds here while scientific research improves and medical practices adopt tailor-made care. Modern cell sorting technology receives rising demand in Asian nations where China, Japan, and South Korea pursue top research in pharmaceuticals and biotechnology. The growing number of patients with chronic illnesses and the large population of this region create strong demand for better medical tests and treatments, which grows the market actively.

Key Players Covered

The report includes the profiles of the following key players:

• Bio-Rad Laboratories, Inc. (U.S.)
• Sino Biological, Inc. (China)
• Thermo Fisher Scientific Inc. (U.S.)
• DH Life Sciences, LLC. (U.S.)
• BD (U.S.)
• Beckman Coulter, Inc. (U.S.)
• Sony Biotechnology Inc. (U.S.)
• Sysmex Corporation (Japan)
• Miltenyi Biotec (Germany)

Key Industry Developments

• In September 2024, Cellares presented a new cell therapy manufacturing technology to the public in September 2024. The new system brought together individual cell therapy production steps, including isolation, stimulation, gene transfer, and growth in a robotic single system.
• In February 2023, Beckman Coulter Life Sciences took the CytoFLEX platform to new heights when it launched the CytoFLEX S6 sorter development. The company invested in developing its CytoFLEX platform to give research scientists better multi-colour flow cytometry by improving the optical components and signal analysis technology.

In January 2023, BD Biosciences introduced their newest FACS-based cell sorter to the market. They launched a project to improve performance on their current platforms with specific emphasis on better speed and accuracy.